Cipla Increases Its Investment in a Digital Technology Startup GoApptiv

Cipla Ltd, a prominent pharmaceutical business, has invested ₹42 crore in GoApptiv, raising its diluted ownership in the digital tech startup to 22.99%.

GoApptiv Private Limited is a business services firm that works in the technology and healthcare industries.

Rajasekhar Parcha and Sreeram Venkitaraman established GoApptiv. With its headquarters in Asia-Pacific (APAC)

Cipla mainly creates medicines to address disorders including depression, diabetes, rheumatoid arthritis, and cardiovascular disease.

Cipla offers its goods in 86 countries and has 47 production facilities worldwide.

which is in line with the company’s ambition to strengthen investments in channels of the future.